학술논문
'학술논문'
에서 검색결과 157건 | 목록
1~10
Academic Journal
Xu EJK; Smith BE; Conce Alberto WD; Walsh MJ; Lim B; Hoffman MT; Qiang L; Dong J; Garmilla A; Zhao QH; Perez CR; Gaglione SA; Dobson CS; Dougan M; Dougan SK; Birnbaum ME
Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Academic Journal
Oberstein PE; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Kawaler EA; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Beri N; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Bollenrucher N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chang E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Dolgalev I; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Werba G; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Lima C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Keheler CE; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Sullivan KM; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Dougan M; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Hajdu C; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Pathology, NYU Langone Health, New York, New York.; Dajee M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Pelletier MR; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Nazeer S; Novartis Pharmaceuticals, Cambridge, Massachusetts.; Squires M; Novartis Pharmaceuticals, Cambridge, Massachusetts.; Bar-Sagi D; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Simeone DM; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE
Academic Journal
Kureshi CT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Program in Immunology, Harvard Medical School, Boston, MA, USA.; Dougan M; Program in Immunology, Harvard Medical School, Boston, MA, USA; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Program in Immunology, Harvard Medical School, Boston, MA, USA. Electronic address: stephanie_dougan@dfci.harvard.edu.
Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE
Academic Journal
Singh H; Dana-Farber Cancer Institute, Boston, MA, United States.; Xiu J; Caris Life Sciences (United States), Phoenix, AZ, United States.; Kapner KS; Dana-Farber/Harvard Cancer Center, Boston, United States.; Yuan C; Dana-Farber Cancer Institute, Boston, MA, United States.; Narayan RR; Loma Linda University Health Care, Loma Linda, CA, United States.; Oberley M; Caris Life Sciences (United States), Phoenix, AZ, United States.; Farrell A; Caris Life Sciences (United States), Tempe, AZ, United States.; Surana R; Dana-Farber Cancer Institute, Boston, MA, United States.; Huffman BM; Dana-Farber Cancer Institute, Boston, MA, United States.; Perez K; Dana-Farber Cancer Institute, Boston, MA, United States.; Cleary JM; Dana-Farber Cancer Institute, Boston, MA, United States.; Jordan AC; Dana-Farber Cancer Institute, Boston, MA, United States.; Dias Costa A; Dana-Farber Cancer Institute, Boston, MA, United States.; Williams HL; Dana-Farber Cancer Institute, Boston, MA, United States.; Raghavan S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Weinberg B; Georgetown University Medical Center, Washington, DC, United States.; Pishvaian MJ; Johns Hopkins Medicine, Washington, DC, United States.; Shroff R; University of Arizona, Tucson, AZ, United States.; Goel S; Rutgers, The State University of New Jersey, New Brunswick, NJ, United States.; Dougan SK; Dana-Farber Cancer Institute, Boston, MA, United States.; Nowak JA; Brigham and Women's Hospital, Boston, MA, United States.; Spetzler D; Caris Life Sciences (United States), Tempe, Az, United States.; Sledge G; Caris Life Sciences (United States), Irving, TX, United States.; Wolpin BM; Dana-Farber/Harvard Cancer Center, Boston, MA, United States.; Aguirre AJ; Dana-Farber Cancer Institute, Boston, MA, United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Patil SU; Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Dougan M; Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston.
Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE
Academic Journal
Dilly J; Dana-Farber Cancer Institute, Boston, MA, United States.; Hoffman MT; Dana-Farber Cancer Institute, Boston, MA, United States.; Abbassi L; Dana-Farber Cancer Institute, Boston, MA, United States.; Li Z; Dana-Farber Cancer Institute, Boston, MA, United States.; Paradiso F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Parent BD; Dana-Farber Cancer Institute, Boston, MA, United States.; Hennessey CJ; Dana-Farber Cancer Institute, Boston, MA, United States.; Jordan AC; Dana-Farber Cancer Institute, Boston, MA, United States.; Morgado M; Dana-Farber Cancer Institute, Boston, MA, United States.; Dasgupta S; Broad Institute, Cambridge, MA, United States.; Uribe GA; Dana-Farber Cancer Institute, Boston, MA, United States.; Yang A; Dana-Farber Cancer Institute, Boston, MA, United States.; Kapner KS; Dana-Farber/Harvard Cancer Center, Boston, United States.; Hambitzer FP; Dana-Farber Cancer Institute, Boston, MA, United States.; Qiang L; Dana-Farber Cancer Institute, Boston, United States.; Feng H; Dana-Farber Cancer Institute, Boston, United States.; Geisberg J; Dana-Farber Cancer Institute, Boston, MA, United States.; Wang J; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, United States.; Evans KE; Dana-Farber Cancer Institute, Boston, MA, United States.; Lyu H; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Schalck A; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Feng N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Lopez AM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Bristow CA; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Kim MP; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Rajapakshe KI; The University of Texas MD Anderson Cancer Center, United States.; Bahrambeigi V; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Roth JA; Broad Institute, Cambridge, MA, United States.; Garg K; Resolution Bioscience, United States.; Guerrero PA; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Stanger BZ; University of Pennsylvania, Philadelphia, Pennsylvania, United States.; Cristea S; Dana-Farber Cancer Institute, Boston, United States.; Lowe SW; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Baslan T; Memorial Sloan Kettering Cancer Center, New York, New York, United States.; Van Allen EM; Dana-Farber Cancer Institute, Boston, MA, United States.; Mancias JD; Dana-Farber Cancer Institute, Boston, MA, United States.; Chan E; Amgen (United States), Thousand Oaks, CA, United States.; Anderson A; Amgen Inc., Thousand Oaks, CA, United States.; Katlinskaya YV; Amgen Inc., Thousand Oaks, CA, United States.; Shalek AK; Massachusetts Institute of Technology, Cambridge, MA, United States.; Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.; Pant S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Hallin J; Mirati Therapeutics (United States), San Diego, CA, United States.; Anderes K; Mirati Therapeutics (United States), San Diego, CA, United States.; Olson P; Mirati Therapeutics (United States), San Diego, CA, United States.; Heffernan TP; The University of Texas MD Anderson Cancer Center, Houston, United States.; Chugh S; Dana-Farber Cancer Institute, Boston, MA, United States.; Christensen JG; Mirati Therapeutics (United States), San Diego, CA, United States.; Maitra A; The University of Texas MD Anderson Cancer Center, United States.; Wolpin BM; Dana-Farber/Harvard Cancer Center, Boston, MA, United States.; Raghavan S; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.; Nowak JA; Brigham and Women's Hospital, Boston, MA, United States.; Winter PS; Massachusetts Institute of Technology, Cambridge, MA, United States.; Dougan SK; Dana-Farber Cancer Institute, Boston, MA, United States.; Aguirre AJ; Dana-Farber Cancer Institute, Boston, MA, United States.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Academic Journal
Aney KJ; Biological and Biomedical Sciences Program, Harvard Medical School, Boston, Massachusetts; Health Sciences & Technology Program, Harvard-MIT, Boston, Massachusetts; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Jeong WJ; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Vallejo AF; University of Southampton, Southampton, United Kingdom.; Burdziak C; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York.; Chen E; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Wang A; Harvard University, Cambridge, Massachusetts.; Koak P; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.; Wise K; Adelaide Centre for Epigenetics (ACE), University of Adelaide, South Australia, Australia; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, South Australia, Australia.; Jensen K; Adelaide Centre for Epigenetics (ACE), University of Adelaide, South Australia, Australia; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, South Australia, Australia; Australian Genome Research Facility, Melbourne, Victoria, Australia.; Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York; Howard Hughes Medical Institute, Chevy Chase, Maryland.; Dougan SK; Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Martelotto L; Adelaide Centre for Epigenetics (ACE), University of Adelaide, South Australia, Australia; South Australian immunoGENomics Cancer Institute (SAiGENCI), University of Adelaide, South Australia, Australia. Electronic address: luciano.martelotto@adelaide.edu.au.; Nissim S; Biological and Biomedical Sciences Program, Harvard Medical School, Boston, Massachusetts; Health Sciences & Technology Program, Harvard-MIT, Boston, Massachusetts; Genetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts; Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: snissim@bwh.harvard.edu.
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Huang YH; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Zhu C; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Kondo Y; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Anderson AC; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Gandhi A; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Russell A; Rosenstiel Basic Medical Sciences Research Center, Brandeis University, 415 South Street, Waltham, 02454, Massachusetts, USA.; Dougan SK; Whitehead Institute, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USA.; Petersen BS; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.; Melum E; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Division of Cancer Medicine, Norwegian PSC Research Center, Surgery and Transplantation, Oslo University Hospital, Oslo 0424, Norway.; Pertel T; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Clayton KL; Department of Immunology, University of Toronto, Toronto, Ontario M5S1A8, Canada.; Raab M; Department of Pathology, Cell Signalling Section, University of Cambridge, Cambridge CB2 1QP, UK.; Chen Q; State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.; Beauchemin N; Goodman Cancer Research Centre, McGill University, Montreal H3G 1Y6, Canada.; Yazaki PJ; Beckman Institute, City of Hope, Duarte, 91010, California, USA.; Pyzik M; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA.; Ostrowski MA; Department of Immunology, University of Toronto, Toronto, Ontario M5S1A8, Canada.; Keenan Research Centre of St. Michael's Hospital, Toronto, Ontario M5S1A8, Canada.; Glickman JN; GI Pathology, Miraca Life Sciences, Newton, 02464, Massachusetts, USA.; Rudd CE; Department of Pathology, Cell Signalling Section, University of Cambridge, Cambridge CB2 1QP, UK.; Ploegh HL; Whitehead Institute, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USA.; Franke A; Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel 24105, Germany.; Petsko GA; Rosenstiel Basic Medical Sciences Research Center, Brandeis University, 415 South Street, Waltham, 02454, Massachusetts, USA.; Kuchroo VK; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, 02115, Massachusetts, USA.; Blumberg RS; Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, 02115, Massachusetts, USA. rblumberg@partners.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.; Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Katz MHG; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bauer TW; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Patel A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Clancy TE; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wang J; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Reilley MJ; Division of Hematology and Oncology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia.; Stucky CH; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona.; Bekaii-Saab TS; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix, Arizona.; Elias R; Hartford Healthcare Cancer Institute, Hartford, Connecticut.; Merchant N; Department of Surgery, University of Miami, Miami, Florida.; Slingluff CL Jr; Department of Surgery, University of Virginia Health System, Charlottesville, Virginia.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Kureshi R; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bello E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.; Kureshi CTS; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Walsh MJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.; Lippert V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hoffman MT; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dougan M; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.; Longmire T; Bristol Myers Squibb, Cambridge, MA, USA.; Wichroski M; Bristol Myers Squibb, Cambridge, MA, USA.; Dougan SK; Department of Immunology, Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Dougan SK
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어